The effect of cholecalciferol injection on serum 25 hydroxy vitamin D and parathyroid hormone in obese and none obese reproductive age women

Pharmaceutical Sciences

Volumn 15, Issue 1, 2009, Pages 9-16

  Ostadrahimi, A ^a   Mahboob, S ^a   Abbasalizad Farhangi, M ^b   Vahed Jabbari, M ^c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

25 hydroxy vitamin D; Body mass index; Obesity; PTH

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCIUM; COLECALCIFEROL; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CALCIUM BLOOD LEVEL; CHEMICAL ANALYSIS; CHEMOLUMINESCENCE; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; DRUG EFFECT; ENDOCRINE SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; INTERVENTION STUDY; METHODOLOGY; OBESITY; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 77958524863     PISSN: 1735403X     EISSN: 23832886     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Popkin B.M. The nutrition transition and its health implications in lower-income countries, Public health nutrition, 1998, 1(1): 1-4.
2. Darnton-Hill I., Coyne E.T. Feast and famine: socioeconomic disparities in global nutrition and health, Public health nutrition, 1998, 1(1): 23-98.
3. Greenberg A.S., Obin M. Obesity and the role of adipose tissue in inflammation and metabolism, American Journal of Clinical Nutrition, 2006, 83 (Suppl): 461-465.
4. World Health Organization. Fact and overweight. Internet: http://www.who.int/dietphysicalactivity/publications/facts/obesity/en.
5. Mokdad A.H., Ford E.S., Bowman B.A. Prevalence of obesity, diabetes and obesity related health risk factors, JAMA, 2003, 289: 76-79.
6. Arunabh S., Pollack S., Yea J., Aloia J.F. Body Fat Content and 25-Hydroxyvitamin D Levels in Healthy Women, J. Clin. Endocrinol. Metab., 2003, 88: 157-161.
7. Zemel M.B., Shi H., Greer B., Dirienzo D., Zemel PC. Regulation of adiposity by dietary calcium, FASEB, 2000, 14: 1132-1138.
8. Lumb G.A., Mawer E.B., Stanbury S.W. The apparent vitamin D resistance of chronic renal failure: a study of the physiology of vitamin D in man, Am. J. Med., 1971, 50: 421-44.
9. Liel Y., Ulmer E., Shary J., Hollis B.W., Bell N.H. Low circulating vitamin D in obesity, Calcif. Tissue Int., 1988, 43: 199-201.
10. Hey H., Stockholm K.H., Lund B.J., Sorenson O.H. Vitamin D deficiency in obese patients and changes in circulating vitamin D metabolites following jejunoileal bypass, Int. J. Obes., 1982, 6: 473-479.
11. Wortsman J., Matsuoka L.Y., Chen T.C., Lu Z., Holick M.F. Decreased bioavailability of vitamin D in obesity, Am. J. Clin. Nutr., 2000, 72: 690-693.
12. th ed, Lippinbcott Williamw and Wilkins, Philadelphia, 2006, 37.
13. Heaney P. Long Latency deficiency disease: Insights from calcium and vitamin D, Am. J. Clin. Nutri., 2003, 78: 912-9.
14. Yanoff L., Shamikh J., Parikh A., Blakeley D., Nancy G. The prevalence of hypovitaminosis D and secondary hyperparathyroidism in obese black Americans, Clin. Endocrinol., 2006, 64: 523-529.
15. Hypponen E., Power C.Vitamin D Status and Glucose Homeostasis in the 1958 British Birth Cohort, Diabetes Care, 2006, 29: 2244-2246.
16. Morreale H.F., Vazquez C, Balsa J.A., Villafruela J.J., Blasco A.F., Carretero J.I. Vitamin D deficiency is associated with metabolic syndrome in morbid obesity, Clin. Nutr., 2007, 26(5): 573-80.
17. Need A.G., O'Loughlin P.D., Horowitz M., Nordin B.E. Relationship between fasting serum glucose, age, body mass index and serum 25-hydroxyvitamin D in postmenopausal women, Clin. Endocrinol., 2005, 62(6): 738-41. (Pubitemid 40825945)
18. Hollis B., Macfarlane G., Valcour A. Clinical significance and assessment of 2 5-hydroxy vitamin D, Advance/Laboratory, 2005, 2: 72-78.
19. Roth H.J., Zahn I., Alkier R., Schmidt H. Validation of the first automated chemiluminescence protein-binding assay for the detection of 25-hydroxycalciferol, Clin. Lab., 2001, 47: 357-365.
20. Maghbooli Z., Hossein Neghad A., Shafaei A., Karimi F., Sadat Mdani F., Larijani B. Vitamin D status in mothers and their newborns in Iran, BMC pregnancy and Childhood birth, 2007, 7: 1.
21. Snijder M., Rob M., Marjolein V., Dorly J., Jacqueline M. Adiposity in Relation to Vitamin D Status and Parathyroid Hormone Levels: A Population-Based Study, J. Clin. Endocrinol. Metab., 2005, 90: 4119-4123.
22. th ed, John Rogers, Philadelphia, 2004, 131-133.
23. Canto-Costa M.H.S., Kunii I., Hauache O.M. Body fat and cholecalciferol supplementation in elderly homebound individuals, Braz. J. Med. Biol. Res., 2006, 39(1): 91-96 and 103.
24. Norman H.B., Shaw S., Turner R.T. Evidence that 1,25-Dihydroxy vitamin D3 inhibits the hepatic production of 25 hydroxy vitamin D in man, The Journal of Clin. Invest., 1984, 74: 1540-1544. (Pubitemid 15200250)
25. Compston J.E., Vedi S., Ledger J.E., Gazet J.C., Pilkington R.E. Vitamin D status and bone histomorphometry in gross obesity, Am. J. Clin. Nutr., 1981, 34: 2359-2363. (Pubitemid 12176062)
26. Kamycheva E., Sundsfjord J., Jorde R. Serum parathyroid hormone level is associated with body mass index, The 5th Tromse study, Eur. J. of Endocrinol., 2004, 151: 167-172 . (Pubitemid 39207010)
27. Grey A.B., Evans M.C., Tapleton J.P., Reid I.R. Body weight and bone mineral density in postmenopausal women with primary hyperparathyroidism, Ann. Intern. Med., 1994, 121: 745-749.
28. Nesby-o D., Scanlon K., Cogswell E., Gillespie C, Hollis B. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey 1988-1994, Am. J. Clin. Nutr., 2002, 76: 187-92.
29. Grootjans G., Wieldres J.P. A pilot study of hypovitaminosis D in apparently healthy, veiled, Turkish women: severe vitamin D deficiency in 82%, Ned. Tijdschr Geneeskd., 2002, 146(23): 1100-1.
30. Ostad Rahimi A., Zarghami N., Sadighi A. Vitamin D and its relationship with nutritional status in healthy reproductive age women, Inter. J. of Endocrinol., 2006, 9: 33-36.
31. Barger-lux M.J., Heaney R.P., Dowell S. Vitamin D and its major metabolites :Serum levels after gradual oral dosing in healthy men, Osteoprosis International, 1998, 8: 222-230. (Pubitemid 28427071)